Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tenax Therapeutics

6.09
-0.0800-1.30%
Volume:6.04K
Turnover:36.62K
Market Cap:25.26M
PE:-6.07
High:6.19
Open:6.19
Low:5.91
Close:6.17
Loading ...

Tenax Therapeutics trading resumes

TIPRANKS
·
21 Jun

Tenax Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
18 Jun

Tenax Therapeutics Reports Increased Losses Amid Strategic Investments

TIPRANKS
·
21 May

Positive Buy Rating for Tenax Therapeutics Driven by Promising Clinical Trials and Strong Financial Position

TIPRANKS
·
19 May

Tenax Therapeutics Inc : Guggenheim Cuts Target Price to $15 From $16

THOMSON REUTERS
·
15 May

William Blair Remains a Buy on Tenax Therapeutics (TENX)

TIPRANKS
·
15 May

Tenax Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Tenax Therapeutics Reports $10.4M Net Loss in Q1 2025, Up from $3.8M Loss in Q1 2024; R&D and G&A Expenses Surge

Reuters
·
15 May

Tenax Therapeutics Q1 EPS $(0.28) Misses $(0.19) Estimate

Benzinga
·
15 May

Tenax Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
09 May

Tenax Therapeutics Advances Cardiopulmonary Therapies

TIPRANKS
·
25 Apr

Tenax Therapeutics files to sell 4.14M shares of common stock for holders

TIPRANKS
·
16 Apr

Tenax Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
26 Mar

Tenax Therapeutics Q4 2024 GAAP EPS $(0.18) Beats $(0.42) Estimate

Benzinga
·
26 Mar

Tenax Therapeutics Inc: Qtrly Loss per Share $0.18

THOMSON REUTERS
·
26 Mar

Tenax Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview

Reuters
·
24 Mar

Tenax Therapeutics Inc : Leerink Partners Raises Target Price to $20 From $16

THOMSON REUTERS
·
10 Mar

Roth MKM Reaffirms Their Buy Rating on Tenax Therapeutics (TENX)

TIPRANKS
·
06 Mar

Tenax Therapeutics expands Phase 3 LEVEL program for TNX-103

TIPRANKS
·
05 Mar

Tenax Therapeutics prices 378,346 shares at $6.04 in private placement

TIPRANKS
·
05 Mar